Wellness & Lifestyle

HFWL Company is a next-generation health-tech and AI innovation group focused on reimagining the future of health and human wellness. It builds an ecosystem of AI healthcare ventures, including FriskaAi for chronic care management, NourIQ Ai for clinical-grade nutrition intelligence, and KlinIQ Ai for AI-powered preventive care. HFWL integrates AI, behavioral science, and data ethics to create real-world impact across clinical care, nutrition, diagnostics, sensory cognition, and neurodevelopment. The company operates globally with a vision to empower individuals to live longer, healthier, and more fulfilled lives through intelligent systems.

KAI Conversations leverages cutting-edge AI to analyze healthcare interactions, providing products and services that empower better conversations and ultimately, healthier lives within the life sciences and pharmaceutical sectors. The platform helps pharma decision-makers achieve stronger field force impact, sharper customer insights, and accelerated brand performance. It also aims to provide better experiences and outcomes for patients, and more valuable engagement for HCPs. KAI supports over 57 languages, analyzes more than 40,000 conversations, and processes over 200,000 data points per conversation across more than 15 therapy areas. It offers tailored solutions for Pharma Commercial Teams, Pharma Medical Teams, and Healthcare Organizations, enabling them to maximize conversation impact, develop world-class coaching cultures, and navigate brand performance in real-time.

Prana Health offers a free AI doctor consultation service, allowing users to chat with an AI health assistant 24/7 to describe symptoms and receive personalized guidance in seconds. This platform is designed to provide instant health answers and help users understand their conditions. For those who require professional medical attention, Prana facilitates connections with licensed physicians for just $39. The service is private, fast, and available around the clock. It also supports prescription services when medically appropriate and ensures HIPAA-aligned security for user data. Prana aims to be a comprehensive solution for initial health inquiries and affordable telehealth visits, available across all 50 US states.

Teton is an AI-powered assistant designed to empower care staff and improve resident monitoring in hospitals and care homes. Utilizing advanced computer vision and AI infrastructure, Teton's sensors detect room activity in real-time with privacy by design, eliminating the need for wearables or manual calibration. The platform offers proactive care tools, providing staff with insights to prioritize and personalize resident care, and integrates seamlessly into existing routines. For leadership, Teton delivers live, resident-to-portfolio analytics for predictive intelligence, helping improve operating income and length of stay. Key features include real-time alerts, silent acknowledgements, and granular data analysis for sleep, mobility, and staff activity, enabling deeper resident understanding and transparent care billing.

The MetaPause is an AI-powered health concierge specifically designed for women navigating perimenopause, menopause, and beyond. It offers personalized supplement and peptide protocols, curated by top doctors in women's health and longevity. The platform utilizes an in-house AI, ELSA, to ask smart questions and integrate data from labs, wearables, genetics, and symptoms to provide a comprehensive health picture. Users receive tailored recommendations for lifestyle shifts, supplements, peptides, and hormones. The MetaPause also features a symptom tracker that generates a "menopause score" to monitor progress, and allows users to track daily well-being and side effects. It aims to provide clarity and control during a confusing stage of health journeys, fostering a supportive community.

jaide is an AI-powered platform designed to assist doctors, particularly in oncology, by automating clinical documentation and providing advanced prognostic models. The AI clinical assistant helps healthcare providers save up to 4 hours per week on documentation by automating note-taking and generating medical reports. This allows doctors to focus more on patient care. Additionally, jaide develops AI prognostic models to anticipate cancer evolution and improve therapeutic decisions, with current models for prostate and colorectal cancer, and lung cancer in development. The platform emphasizes quick setup, flexibility, secure HDS data storage (GDPR compliant), FHIR data export, EHR integration, and a user-friendly interface with 1-click launch for AI consultations and dictation.

AI Medical Service Inc. is a medical AI startup dedicated to eliminating missed cancer diagnoses through advanced endoscopy AI. The company develops image diagnostic support AI, such as the "gastroAI model-G2" for gastric cancer differentiation and "gastroAI model-EIRL" for colorectal polyps. These software solutions detect suspicious regions in endoscopic images, assisting doctors in early diagnosis. Additionally, they offer "gastroBASE screening X," a cloud-based image interpretation platform for various diagnostic devices. Their mission is to save lives globally by enabling early cancer detection, particularly in regions with limited access to skilled endoscopists.

NirogGyan is a comprehensive platform designed to transform medical reporting for diagnostic labs and hospitals. It simplifies complex medical jargon into clear, actionable insights, ensuring greater patient engagement and satisfaction. Key features include AI-powered smart reports with plain-language interpretations and recommendations, a mobile-friendly Viz App for patients and clinicians, and a Lab Report Analyzer for quality assurance and operational excellence. The platform also offers seamless LIS integrations, real-time analytics dashboards for performance monitoring, and health tools like risk calculators. NirogGyan aims to reduce report generation time, eliminate human errors, and provide instant visibility into lab performance, ultimately improving patient understanding and operational efficiency.

iHairium is a comprehensive AI platform designed to improve hair and scalp health for individuals and businesses. It offers a mobile application for AI-powered hair and scalp diagnosis, personalized haircare plans, and online consultations with trichologists, dermatologists, and nutritionists. Users can also find and book clinics for hair transplants and other treatments. For businesses, iHairium provides SDK/API solutions for e-commerce, salons, and telemedicine platforms, enabling them to integrate AI diagnostics, personalized product recommendations, and clinic management tools. The platform aims to make hair and scalp care smarter, simpler, and more profitable through cutting-edge AI technology.

CurieDx offers an AI-powered solution for screening strep throat, leveraging smartphone image analysis. The tool, branded as StrepAI, is available as an app for iPhone users, providing a convenient and accessible way for patients to screen for strep throat from home. Additionally, CurieDx extends its services to urgent care practices, suggesting its utility in professional medical settings for initial assessments. This innovative approach aims to streamline the diagnostic process, potentially reducing the need for immediate in-person visits for preliminary strep throat screening. The focus on image-based prediction highlights a modern application of AI in health diagnostics.

Tricog Health offers an AI-powered platform designed to accelerate cardiac care diagnosis and improve patient outcomes. The platform combines medical-grade Artificial Intelligence, advanced technology, and human medical expertise to provide accurate and timely diagnoses for heart conditions. Tricog's solutions, including InstaECG, InstaEcho, VCardia, and KeeboHealth, cater to clinics, hospitals, diagnostic centers, public health initiatives, and home health services. The system digitizes ECG/EKG workflows, provides cloud-based access to patient information, and integrates with existing LIS systems. By addressing gaps in timely access and quality of care, Tricog aims to reduce premature mortality and morbidity caused by cardiovascular diseases.

RETFound is an open-source vision foundation model project hosted on GitHub, dedicated to medical AI applications, particularly for retinal image analysis. It provides a series of foundation models, including its namesake RETFound, as well as integrations with DINOv2 and DINOv3 from Meta. The project emphasizes self-supervised learning, having been pre-trained on 1.6 million retinal images, and has demonstrated effectiveness in various disease detection tasks. Key features include its ability to be efficiently adapted to customized tasks and its generalizability for disease detection. The repository offers detailed instructions for environment setup, fine-tuning with pre-trained weights available on HuggingFace, and evaluation procedures, making it a valuable resource for researchers and developers in medical imaging AI.

CULTZYME is a deep-tech company focused on developing innovative technologies for intelligent bioprocesses. They offer a full-stack bioprocessing platform that integrates advanced hardware with AI capabilities to autonomously optimize biotech production. The platform aims to significantly improve and streamline various biotech processes, enhancing efficiency and potentially reducing operational complexities. By leveraging artificial intelligence, CULTZYME seeks to provide solutions that can adapt and learn, leading to more efficient and precise control over bioproomanufacturing workflows.

nSight Surgical is a pioneering artificial intelligence platform that leverages computer vision to revolutionize surgical operations. It acts as a consistent observer, collecting and reporting critical data on efficiency, quality, and cost to health centers. The platform offers detailed surgical phase times, allowing teams to analyze and improve performance. It provides data science as a service, helping identify benchmarks and incentivize surgical teams. For the first time, OR managers and clinical teams gain access to comprehensive efficiency, case costing, and quality data, enabling operational transformation. Key features include efficiency insights for workflow optimization, quality insights for retained foreign object prevention and sterile field monitoring, and cost insights for detailed inventory tracking and waste reduction.

Caranx Medical, now operating under the Carvolix brand, is at the forefront of transforming cardiac valve replacement and ischemic stroke treatment through AI-driven mini-robotics. The company focuses on conditions with significant unmet clinical needs and limited patient access to effective therapies. Their platform supports interventional cardiologists in complex procedures by providing AI- and imaging-driven mini-robotic technologies. These mini-robots operate with supervised autonomy, guided by real-time imaging and artificial intelligence, assisting with navigation and positioning. The goal is to improve procedural efficiency, safety, and patient outcomes, ultimately expanding access to advanced procedures by enabling a broader base of physicians to perform them with greater precision and confidence.

LinkMD AI is a leading agentic AI ecosystem specifically designed for healthcare Revenue Cycle Management (RCM). It empowers healthcare providers by automating critical administrative tasks, allowing them to prioritize patient care. The platform offers several specialized AI agents, including Eligibility AI for instant insurance verification and cost estimates, Authorization AI for automated prior authorization submissions and appeals, and Compliance AI to ensure pre-surgery patient requirements are met. Additionally, OpNote AI generates structured operative reports in real-time during surgery, predicting CPT codes for accurate billing, while Claims AI handles end-to-end claim submission, scrubbing for denials, and managing rejections. LinkMD AI emphasizes its specialty-focused AI agents, trained on clinical guidelines and practice workflows, and guarantees ROI.

PV.app is an AI-powered cloud solution designed to streamline drug safety reporting and pharmacovigilance for pharmaceutical companies and related organizations. The platform is ICH E2B R3 compliant and supports MedDRA & WHODrug dictionaries, ensuring regulatory adherence. It facilitates adverse event reporting, allowing medical liaisons, doctors, pharmacists, patients, and caregivers to submit reports directly to pharmaceutical companies and regulators. PV.app also supports Post-Authorisation Safety Studies (PASS) by enabling direct patient report collection. The solution is validated in accordance with GAMP5, GxP, and 21 CFR P.11 (Annex 11) compliant, offering robust data security with redundant cloud storage, audit trails, and certified data centers following GDPR & HIPAA standards. It provides multidevice support, offline reporting capabilities, and automated generation of XML, CIOMS, and PDF formats for regulatory submissions.

Docus is an AI-powered health platform designed for diagnostic labs, doctors, and patients. For labs, it automates test result interpretation, follow-up recommendations, and compliance checks, helping to reduce operational costs and improve retention. Doctors benefit from AI-generated clinical reports, decision support, and patient messaging with AI auto-complete. Patients receive easy-to-understand reports and can interact with an AI health assistant for personalized insights. The platform supports a wide range of tests, integrates with existing lab systems via API/HL7, and offers secure, HIPAA-compliant data handling. Docus aims to enhance engagement, boost retention, and drive growth across various lab models, including direct-to-consumer, reference, and in-house labs.

OneTwenty AG is at the forefront of diabetes technology, developing AI-powered solutions for insulin pumps, smart pens, and other medical devices. Their core technology, bioX®, offers three main applications: bioX® neoAP for learning closed-loop automatic insulin delivery, bioX® DT for creating digital twins to predict biomarkers and health events, and bioX® sensAI for optimizing sensor data translation with groundbreaking accuracy. Built on massive datasets, bioX® is designed to be ultra-lightweight for direct deployment on SoCs and is HIPAA compliant. The company aims to provide peace of mind for people living with diabetes by making care smarter, more reliable, and more reassuring.

Deep Longevity leads the way in advanced longevity technology, offering AI-powered aging clocks to enhance healthspan and lifespan. The platform provides personalized health insights designed to drive preventive care and early interventions by tailoring diet, exercise, and lifestyle recommendations. Their commercially available aging clocks include Blood Age, Mind Age, Biometric Age, and Epigenetic Age. Deep Longevity offers cutting-edge SaaS platforms, SenoClock and SenoClock Gold, enabling the generation of Biological Age predictions and comprehensive Health Summary Reports for enterprise customers. These reports provide a nuanced analysis of health and longevity, identifying specific organ health aspects needing attention and offering personalized recommendations in lifestyle, nutrition, and supplements.

BobiHealth is an AI-powered mobile application designed to support individuals through their pregnancy journey. It offers tailored care, real-time alerts, and essential health tracking tools, aiming to make pregnancy safer by leveraging advanced technology and ethical AI. The app helps users monitor their health and their baby's well-being, providing peace of mind, especially for those with high-risk pregnancies. BobiHealth has been recognized as a "Top Pregnancy Health Tracking Tool 2025" by Healthcare Tech Outlook magazine, highlighting its innovative approach to maternal health. The platform is committed to reducing avoidable maternal and infant mortality by delivering vital, evidence-based information and integrating clinical insights with cutting-edge technology.

Nephrolytics offers an AI-powered platform designed to transform nephrology care, recognized as a leading solution in 2025. Its core offering, Saya™, is the first AiPOC (Agentic Infrastructure for Point-of-Care) built for kidney care, streamlining workflows, reducing burnout, and enabling real-time clinical decisions. Saya™ unifies patient data, auto-generates SOAP notes, and surfaces clinical insights in a zero-click interface. Complementing Saya™ is Lumi™, an AI-powered financial analytics tool providing real-time insights into revenue performance, resource allocation, and predictive modeling for nephrology practices. The platform also includes Syncra™ for practice orchestration and Revina™ for automated RCM, aiming to drive impact from point of care to back office. Nephrolytics helps practices achieve a 40% reduction in documentation time, a 33% increase in coding accuracy, and a 19% increase in revenue per provider.

RheumaFinder is an AI-powered application designed for the opportunistic detection of structural bone lesions (erosion and ankylosis) in the sacroiliac joints from routine CT studies. It integrates seamlessly as a cloud-native, PACS-agnostic add-on, empowering radiologists to identify patients with structural joint damage who might otherwise go undiagnosed. By leveraging AI as an 'extra pair of eyes,' RheumaFinder supports earlier diagnosis, potentially preventing irreversible joint damage and improving patient quality of life. The software has demonstrated high sensitivity and specificity in clinical validation for detecting joint erosion and ankylosis, and is offered as a Software-as-a-Service with a pay-per-use model, compliant with GDPR and HIPAA regulations.

Svar is an AI-powered platform designed to support therapists and families in delivering effective home-based therapy for children with developmental delays. The platform empowers therapists by providing tools for supervised home therapy, helping to ensure consistent practice and progress tracking. For families, Svar simplifies the therapy process, making it easier to implement therapeutic exercises at home and reducing the burden of documentation. By leveraging AI, Svar aims to make therapy more accessible, consistent, and impactful for children, ultimately improving outcomes and supporting both clinical professionals and caregivers in their roles.